Brief: REGENXBIO Announces Regulatory Update on RGX-121 BLA for MPS II
09/02/2026 21:53
Feb 9 (Reuters) - Regenxbio Inc RGNX.O: REGENXBIO ANNOUNCES REGULATORY UPDATE ON RGX-121 BLA FOR MPS II REGENXBIO INC - FDA ISSUES COMPLETE RESPONSE LETTER FOR RGX-121 REGENXBIO INC - PLANS TO RESUBMIT BLA FOR RGX-121 REGENXBIO INC - REQUESTS TYPE A MEETING WITH FDA TO DISCUSS RGX-121 CRL Source text: ID:nPn7Q6Lrra Further company coverage: RGNX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on REGENXBIO
See all newsBrief: Regenxbio says Sarepta To Pay $39 Million To Regenxbio Within 10 Days Of Effective Date
Regenxbio climbs as new director buys nearly $1 million of stock
Brief: Regenxbio Strengthens Board Of Directors With Appointment Of Greg Ciongoli
U.S. STOCKS ON THE MOVE-Strategy, Ecovyst, Azenta
U.S. STOCKS ON THE MOVE-Azenta, Qiagen NV, Capricor Therapeutics